Single-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses
Preprint
- 21 May 2025
- preprint
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 14
Abstract
Understanding the perturbed lung immune cells distribution and its functionality in tuberculosis (TB) is well documented; however, limited reports have covered their disruption, if any, in diabetes-tuberculosis (DM-TB) comorbid conditions. Here, we employed single-cell RNA-seq to investigate the molecular mechanisms that govern the heterogeneity in host immune response in DM-TB comorbid conditions. Diabetes is associated with chronic hyperinflammation and reduced lung-infiltrating immune cells, which delays the immune response to Mycobacterial infection. scRNA-seq of lung CD3⁺ and CD11c⁺ cells revealed compromised adaptive and innate immunity, with decreased Th1 and M1 macrophage populations in DM-TB mice. A dampened immune response, marked by increased IL-16 signaling and reduced TNF and IFN-II responses, was observed in DM-TB. This study highlights chronic inflammation, hyperglycemia, and dyslipidemia associated with diabetes impairing anti-TB immunity. Selective inhibition of aberrant IL-16 secretion and Th17 cell activation might provide strategies for better managing DM-TB comorbidity.Keywords
All Related Versions
This publication has 60 references indexed in Scilit:
- Diabetes mellitus—Progress and opportunities in the evolving epidemicCell, 2024
- The presence of cytotoxic CD4 and exhausted-like CD8+ T-cells is a signature of active tuberculosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024
- Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytesCell Reports, 2022
- LIGHT (TNFSF14) inhibits glucose uptake of adipocytes by downregulating GLUT4 expression via AKT signaling pathwayBiochemical and Biophysical Research Communications, 2021
- FOXO1 constrains activation and regulates senescence in CD8 T cellsCell Reports, 2021
- The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitusBiomedicine & Pharmacotherapy, 2018
- Inflammageing and metaflammation: The yin and yang of type 2 diabetesAgeing Research Reviews, 2018
- LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitroDiabetologia, 2016
- Diabetes and immunity to tuberculosisEuropean Journal of Immunology, 2014
- Regulation of adipocytokines and insulin resistanceDiabetologia, 2003